Ningshu Liu

1.7k citations
30 papers · 1.1k indexed · h-index 11
Topics
PI3K/AKT/mTOR signaling in cancer (15 papers)Chronic Lymphocytic Leukemia Research (7 papers)Advanced Breast Cancer Therapies (5 papers)
Partner nations
GermanySingaporeChina

In The Last Decade

Ningshu Liu

27 papers receiving 1.1k citations

Peers

Ningshu Liu
Comparison fields: 5 of 75
  • Molecular Biology 561
  • Immunology 340
  • Oncology 275
  • Genetics 225
  • Pathology and Forensic Medicine 224
Replace Helena Mora-Jensen with:
Helena Mora-Jensen Denmark
Carmela Gurrieri Italy
Mònica López‐Guerra Spain
Fanny Baran‐Marszak France
Laurence Cooke United States
Lixin Rui United States
Murali Gururajan United States
Nikhil Mukhi United States
Michaela Prchal‐Murphy Austria
Jennifer DeVecchio United States
Ningshu Liu relative to Helena Mora-Jensen Denmark Helena Mora-Jensen's profile →
Citations per field
00.5×1.5×1.9×
Helena Mora-Jensen · 1×
Citations per year

Countries citing papers authored by Ningshu Liu

Since Specialization
Citations

This map shows the geographic impact of Ningshu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningshu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningshu Liu more than expected).

Fields of papers citing papers by Ningshu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningshu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningshu Liu. The network helps show where Ningshu Liu may publish in the future.

Co-authorship network of co-authors of Ningshu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ningshu Liu. A scholar is included among the top collaborators of Ningshu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningshu Liu. Ningshu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 7
3 72
4 20
5 6
6 101
7 3
8 51
9 2
10 0
11 158
12 10
13 1
14 206
15 0
16 1
17 2
18 247
19 1
20 116

About Ningshu Liu

Ningshu Liu is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (15 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Genetics (225 citations), Immunology (340 citations) and Pathology and Forensic Medicine (224 citations). Ningshu Liu has collaborated with scholars based in Germany, Singapore and China. Frequent co-authors include Lin Ni, Kevin B. Bacon, Shizuo Akira, Dominik Mumberg, Kiyoko Fukami, Hou‐Yong Yu, Tadaomi Takenawa, Karl Ziegelbauer, Claudia Schneider and William J. Scott. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026